- Home
- MRNA vs FTS Comparison
MRNA vs FTS Comparison
Compare MRNA & FTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | FTS |
|---|---|---|
| Founded | 2010 | 1885 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 29.5B |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MRNA | FTS |
|---|---|---|
| Price | $137.95 | $54.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 2 |
| Target Price | $34.27 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 25.3M | 663.0K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.22% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | $11.05 |
| Revenue Next Year | $15.43 | $5.32 |
| P/E Ratio | ★ N/A | $22.72 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $48.69 |
| 52 Week High | $176.66 | $59.40 |
Technical Indicators
Market Signals| Indicator | MRNA | FTS |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 37.46 |
| Support Level | $41.01 | $54.82 |
| Resistance Level | $176.66 | $58.05 |
| Average True Range (ATR) | 13.95 | 0.71 |
| MACD | 5.94 | -0.11 |
| Stochastic Oscillator | 67.07 | 18.36 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving 3.5 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.